Literature DB >> 11739352

The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy.

A Sessa1, B Costa, F Bamfi, G Bettoncelli, G D'Ambrosio.   

Abstract

OBJECTIVES: This study investigated the epidemiology, natural history and resource use associated with influenza in the general population setting in Italy.
METHODS: For a 3-month winter epidemic period, 202 GPs reported daily the number of visits performed for influenza-like illness (ILI), clinical influenza and any other cause. In addition, the first 10 cases of clinical influenza requiring a doctor's visit in each month of the 3-month period and for a total of 30 cases per GP were recorded carefully and followed-up, for evaluation of clinical evolution, associated outcomes and resource use.
RESULTS: Almost 200 000 visits were performed by 202 GPs, ILI and clinical influenza accounting for 13.8 and 8.3% of all-cause visits, respectively. A total of 6057 cases of clinical influenza were also recorded and evaluated for associated outcomes and resource use. Twenty percent of the patients were at risk because they were elderly (>65 years) or presented with concomitant chronic conditions. Almost all the patients received at least one prescription for symptomatic drugs and 36% received a prescription for antibiotics. Thirty-five percent of patients had at least one complication from influenza, primarily upper and lower respiratory tract bacterial infections. At-risk patients had a significantly higher complication rate (odds ratio = 2.89) and required more instrumental exams and hospitalizations compared with the general population, accounting for most of the direct costs associated with clinical influenza. Patients with clinical influenza had an average of 5 days absence from work or school.
CONCLUSIONS: Influenza is associated with significant morbidity in the general and at-risk population, a high degree of resource use in the at-risk population and substantial reduction or loss of productivity in the active working Italian population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739352     DOI: 10.1093/fampra/18.6.629

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  18 in total

1.  Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays.

Authors:  Fabrice Carrat; Michael Schwarzinger; Bruno Housset; Alain-Jacques Valleron
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  The burden of influenza-like illness in the US workforce.

Authors:  Y Tsai; F Zhou; I K Kim
Journal:  Occup Med (Lond)       Date:  2014-03-22       Impact factor: 1.611

3.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

4.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

Review 5.  The impact of influenza on working days lost: a review of the literature.

Authors:  Martin Keech; Paul Beardsworth
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Computerized general practice based networks yield comparable performance with sentinel data in monitoring epidemiological time-course of influenza-like illness and acute respiratory illness.

Authors:  Carla Truyers; Emmanuel Lesaffre; Stefaan Bartholomeeusen; Bert Aertgeerts; René Snacken; Bernard Brochier; Fernande Yane; Frank Buntinx
Journal:  BMC Fam Pract       Date:  2010-03-22       Impact factor: 2.497

Review 7.  Reducing the burden of influenza-associated complications with antiviral therapy.

Authors:  B R Ruf; T Szucs
Journal:  Infection       Date:  2009-05-26       Impact factor: 3.553

8.  Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.

Authors:  Oliver Damm; Martin Eichner; Markus Andreas Rose; Markus Knuf; Peter Wutzler; Johannes Günter Liese; Hagen Krüger; Wolfgang Greiner
Journal:  Eur J Health Econ       Date:  2014-05-25

9.  in silico surveillance: evaluating outbreak detection with simulation models.

Authors:  Bryan Lewis; Stephen Eubank; Allyson M Abrams; Ken Kleinman
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-23       Impact factor: 2.796

10.  Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis.

Authors:  A Pitrelli
Journal:  J Prev Med Hyg       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.